# Correction: Real-world outcomes of immune checkpoint inhibitors as second-line therapy for extensive-stage small-cell lung cancer: a multicenter retrospective analysis

**Authors:** Jiao Zhang, Jia-xing Guo, Ping Li, Xiao-ye Jin, Yan Wang, Lu-jun Zhao

PMC · DOI: 10.3389/fimmu.2025.1708889 · Frontiers in Immunology · 2025-10-08

## Full-text entities

- **Diseases:** small-cell lung cancer (MESH:D055752)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12541319/full.md

---
Source: https://tomesphere.com/paper/PMC12541319